Home › Melanoma › Florida › Coral Springs
Melanoma clinical trials in Coral Springs, FL
5 studies for Melanoma are looking for participants at sites in and around Coral Springs (within about 30 miles). Open a study to see who can join and how to contact the study team.
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Coral Springs
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecruitingPhase 3
- Boca Raton Clinical Research (BRCR) Global, Tamarac · 4 mi away
Pan-tumor MRD Study
RecruitingObservational study
- Oncology & Hematology Associates of West Broward, Coral Springs
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site 109, Tamarac · 4 mi away
- Research Site 127, Margate · 4 mi away
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- University of Miami Sylvester Cancer Center at Coral Springs, Coral Springs
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN32 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- Atlanta, GA21 studies
- Columbus, OH21 studies
- Salt Lake City, UT21 studies
- Durham, NC21 studies
Other studies in Coral Springs
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Colorectal Cancer5 studies
- Atopic Dermatitis (Eczema)4 studies
- Atherosclerosis4 studies
- Multiple Myeloma4 studies
- Breast Cancer4 studies
- Overweight4 studies
- Obesity4 studies
- Diabetic Foot4 studies
- Rheumatoid Arthritis4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.